Lambton public health inspection program expands, rebrands - Sarnia Observer

There will be space for about 300 more students in Lambton College next year. Lambton College is among the post secondary institutions which submitted a proposal for more classroom spots for in demand fields.

SarniaBy Stephanie ChavesOctober 12, 2026 - 6:30amWhile a measles outbreak continues to spread in the United States, local health officials say there has been no uptick in cases here. Recently, New York declared a statewide emergency over a measles outbreak. So far this year, New York has reported 108 cases of the virus. The Centers for Disease Control and Prevention said, as of October 1, there were 3,887 confirmed measles cases in the United States, and over 350 have required hospitalization. Lambton Public Health (LPH) Supervisor of Health Protection Carshenan Lai told Sarnia News Today, there's no word on outbreak concerns locally. "We haven't really received any information from the Ministry of Health that we're looking at a measles outbreak locally," said Lai. "We definitely monitor the situation and our measles vaccine rates are above the provincial average. So, to my knowledge, locally we're not looking at any risks that we've been communicated to by the ministry. "Lai noted residents should make sure they and their children have up-to-date vaccinations.

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.